Struggling Xcyte Therapies, Inc. Cuts Offices
The decline of Xcyte Therapies Inc. appears to be accelerating. The struggling Seattle biotechnology company is vacating more than half its office space, giving up 12,630 square feet at its headquarters near Swedish Medical Center, according to a Dec. 2 filing with the U.S. Securities and Exchange Commission.